{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:51:37Z","timestamp":1770897097967,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.cjca.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,1,11]],"date-time":"2021-01-11T18:22:44Z","timestamp":1610389364000},"page":"621-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evidence-Based Management of Acute Heart Failure"],"prefix":"10.1016","volume":"37","author":[{"given":"Arjun K.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Tomasoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Sidhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Metra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin A.","family":"Ezekowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2021.01.002_bib1","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib2","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1093\/eurheartj\/ehv066","volume":"36","author":"Mebazaa","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nrcardio.2016.25","article-title":"Epidemiology and aetiology of heart failure","volume":"13","author":"Ziaeian","year":"2016","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib5","first-page":"1450","article-title":"The need for heart failure advocacy in Canada","volume":"33","author":"Virani","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1161\/HHF.0b013e318291329a","article-title":"Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association","volume":"6","author":"Heidenreich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib7","doi-asserted-by":"crossref","first-page":"E365","DOI":"10.9778\/cmajo.20150130","article-title":"The current and future financial burden of hospital admissions for heart failure in Canada: a cost analysis","volume":"4","author":"Tran","year":"2016","journal-title":"CMAJ Open"},{"key":"10.1016\/j.cjca.2021.01.002_bib8","author":"Blake"},{"key":"10.1016\/j.cjca.2021.01.002_bib9","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.002_bib10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11897-017-0351-y","article-title":"Acute heart failure: definition, classification and epidemiology","volume":"14","author":"Kurmani","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cjca.2021.01.002_bib11","series-title":"National Heart Failure Audit 2015\u20132016. National Institute for Cardiovascular Outcomes Research (NICOR)","author":"Donkor","year":"2017"},{"key":"10.1016\/j.cjca.2021.01.002_bib12","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","article-title":"Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes","volume":"70","author":"Shah","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jchf.2017.12.012","article-title":"Preventing readmission after hospitalization for acute heart failure: a quest incompletely fulfilled","volume":"6","author":"Fleg","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jacc.2013.11.053","article-title":"The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries","volume":"63","author":"Ambrosy","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib16","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1093\/eurheartj\/ehl193","article-title":"EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population","volume":"27","author":"Nieminen","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","article-title":"Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF","volume":"168","author":"Fonarow","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nrcardio.2016.163","article-title":"Neurohormonal activation in heart failure with reduced ejection fraction","volume":"14","author":"Hartupee","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib19","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib20","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1001\/jama.2009.2","article-title":"BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial","volume":"301","author":"Pfisterer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1100171","article-title":"Effect of nesiritide in patients with acute decompensated heart failure","volume":"365","author":"O\u2019Connor","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s11897-017-0337-9","article-title":"Inflammation: cause or consequence of heart failure or both?","volume":"14","author":"Van Linthout","year":"2017","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.cjca.2021.01.002_bib23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10741-019-09875-1","article-title":"Various aspects of inflammation in heart failure","volume":"25","author":"Dutka","year":"2020","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2021.01.002_bib24","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart failure: JACC State-of-the-Art Review","volume":"75","author":"Murphy","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib25","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ehf2.12439","article-title":"Clinical profiles in acute heart failure: an urgent need for a new approach","volume":"6","author":"Chapman","year":"2019","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/eurheartj\/ehi044","article-title":"Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology","volume":"26","author":"Nieminen","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib27","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/ejhf.1549","article-title":"Time to update our profiles","volume":"21","author":"Punnoose","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib28","doi-asserted-by":"crossref","first-page":"e840","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association","volume":"139","author":"Rangaswami","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.002_bib29","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jacc.2007.09.043","article-title":"Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?","volume":"51","author":"Mullens","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jacc.2003.07.031","article-title":"Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure","volume":"43","author":"Forman","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib32","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jacc.2012.01.077","article-title":"Cardiorenal syndrome type 1: pathophysiological crosstalk leading to combined heart and kidney dysfunction in the setting of acutely decompensated heart failure","volume":"60","author":"Ronco","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib33","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCULATIONAHA.115.020894","article-title":"Gastrointestinal and liver issues in heart failure","volume":"133","author":"Sundaram","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.002_bib34","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1093\/eurheartj\/eht246","article-title":"Interactions of the heart and the liver","volume":"34","author":"M\u00f8ller","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/eurjhf\/hfs007","article-title":"Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial","volume":"14","author":"Ambrosy","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib36","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.hfc.2019.08.009","article-title":"Sleep breathing disorders in heart failure","volume":"16","author":"Coniglio","year":"2020","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.cjca.2021.01.002_bib37","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijcard.2014.10.087","article-title":"Heart failure and cognitive dysfunction","volume":"178","author":"Ampadu","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib39","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2006.06.055","article-title":"Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes","volume":"48","author":"Rutledge","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-015-9517-4","article-title":"Depression and anxiety as predictors of mortality among heart failure patients: systematic review and meta-analysis","volume":"21","author":"Sokoreli","year":"2016","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.cjca.2021.01.002_bib41","first-page":"316","article-title":"Cognitive impairment in heart failure patients","volume":"11","author":"Leto","year":"2014","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib42","first-page":"1649","article-title":"Prognostic value of delirium in patients with acute heart failure in the intensive care unit","volume":"36","author":"Iwata","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib44","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/S0140-6736(00)02060-2","article-title":"Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations","volume":"355","author":"Troughton","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.01.002_bib45","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1001\/jama.2017.10565","article-title":"Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"318","author":"Felker","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib46","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/eurheartj\/ehv010","article-title":"The kidney in heart failure: an update","volume":"36","author":"Damman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib47","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/01.CIR.0000165065.82609.3D","volume":"111","author":"Klein","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.002_bib48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/eurjhf\/hfs099","article-title":"Relationship of serum sodium concentration to mortality in a wide spectrum of heart failure patients with preserved and with reduced ejection fraction: an individual patient data meta-analysis\u2020","volume":"14","author":"Rusinaru","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib49","first-page":"1342","article-title":"2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure","volume":"33","author":"Ezekowitz","year":"2017","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/jamainternmed.2015.6190","article-title":"Use of pulmonary artery catheterization in US patients with heart failure, 2001-2012","volume":"176","author":"Pandey","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib51","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-156-11-201206050-00003","article-title":"Prediction of heart failure mortality in emergent care: a cohort study","volume":"156","author":"Lee","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib52","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cjco.2019.03.003","article-title":"External validation and refinement of emergency heart failure mortality risk grade risk model in patients with heart failure in the emergency department","volume":"1","author":"Sepehrvand","year":"2019","journal-title":"CJC Open"},{"key":"10.1016\/j.cjca.2021.01.002_bib53","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib54","doi-asserted-by":"crossref","first-page":"e002912","DOI":"10.1161\/CIRCHEARTFAILURE.115.002912","article-title":"Validation and comparison of seven mortality prediction models for hospitalized patients with acute decompensated heart failure","volume":"9","author":"Lagu","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib55","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/heartjnl-2013-303632","article-title":"A\u00a0novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score","volume":"100","author":"Salah","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2021.01.002_bib56","article-title":"External validation of the ELAN-HF score, predicting 6-month all-cause mortality in patients hospitalized for acute decompensated heart failure","volume":"8","author":"Salah","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.01.002_bib57","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1503\/cmaj.091117","article-title":"Derivation and validation of an index to predict early death or unplanned readmission after discharge from hospital to the community","volume":"182","author":"van Walraven","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/j.cjca.2021.01.002_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2261-14-97","article-title":"Using the LACE index to predict hospital readmissions in congestive heart failure patients","volume":"14","author":"Wang","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.cjca.2021.01.002_bib59","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/acem.12056","article-title":"A\u00a0risk scoring system to identify emergency department patients with heart failure at high risk for serious adverse events","volume":"20","author":"Stiell","year":"2013","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib60","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/acem.13141","article-title":"Prospective and explicit clinical validation of the ottawa heart failure risk scale, with and without use of quantitative NT-pro BNP","volume":"24","author":"Stiell","year":"2017","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib61","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1161\/CIR.0000000000000509","volume":"136","author":"Yancy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2021.01.002_bib62","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1002\/ejhf.1922","article-title":"Epidemiology, pathophysiology and contemporary management of cardiogenic shock: a position statement from the Heart Failure Association of the European Society of Cardiology","author":"Chioncel","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib63","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pcad.2020.04.007","article-title":"Acute heart failure: more questions than answers","volume":"63","author":"Tomasoni","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2021.01.002_bib64","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1093\/eurheartj\/ehp292","article-title":"Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials","volume":"30","author":"Cheng","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib65","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jchf.2016.03.026","article-title":"Oxygen therapy in patients with acute heart failure: friend or foe?","volume":"4","author":"Sepehrvand","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa0707992","article-title":"Noninvasive ventilation in acute cardiogenic pulmonary edema","volume":"359","author":"Gray","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/eurheartj\/ehx580","article-title":"Indications and practical approach to non-invasive ventilation in acute heart failure","volume":"39","author":"Masip","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib68","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib69","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ejhf.1369","article-title":"The use of diuretics in heart failure with congestion: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"21","author":"Mullens","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib70","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrcardio.2014.215","article-title":"Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy","volume":"12","author":"ter Maaten","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib71","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.amjmed.2014.12.020","article-title":"Substantial discrepancy between fluid and weight loss during acute decompensated heart failure treatment","volume":"128","author":"Testani","year":"2015","journal-title":"Am J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib72","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/ejhf.1753","article-title":"Clinical importance of urinary sodium excretion in acute heart failure","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib73","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2 suppl","key":"10.1016\/j.cjca.2021.01.002_bib74","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1136\/hrt.72.2_Suppl.S40","article-title":"Pharmacokinetics of loop diuretics in congestive heart failure","volume":"72","author":"Brater","year":"1994","journal-title":"Br Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib75","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1002\/ejhf.890","article-title":"Clinical phenotypes and outcome of patients hospitalized for acute heart failure: the ESC Heart Failure Long-Term Registry","volume":"19","author":"Chioncel","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib76","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib77","article-title":"Outcomes associated with a strategy of adjuvant metolazone or high-dose loop diuretics in acute decompensated heart failure: a propensity analysis","volume":"7","author":"Brisco-Bacik","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.01.002_bib78","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib79","first-page":"1097","article-title":"Spironolactone in acute heart failure patients with renal dysfunction and risk factors for diuretic resistance: from the ATHENA-HF trial","volume":"35","author":"Greene","year":"2019","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib80","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to increase natriuresis in congestive heart failure at high risk for diuretic resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib81","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ejhf.1673","article-title":"European Society of Cardiology\/Heart Failure Association position paper on the role and safety of new glucose-lowering drugs in patients with heart failure","volume":"22","author":"Seferovi\u0107","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib82","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib83","doi-asserted-by":"crossref","DOI":"10.1177\/1753944719894509","article-title":"Importance of sodium-glucose cotransporter 2 inhibitor use in diabetic patients with acute heart failure","volume":"13","author":"Kambara","year":"2019","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2021.01.002_bib84","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib85","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.jacc.2016.12.035","article-title":"Short-term effects of tolvaptan in patients with acute heart failure and volume overload","volume":"69","author":"Konstam","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib86","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jacc.2016.09.004","article-title":"Efficacy and Safety of tolvaptan in patients hospitalized with acute heart failure","volume":"69","author":"Felker","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib87","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ijcard.2014.03.020","article-title":"Hypertonic saline with furosemide for the treatment of acute congestive heart failure: a systematic review and meta-analysis","volume":"173","author":"Gandhi","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib88","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jchf.2019.10.012","article-title":"Real world use of hypertonic saline in refractory acute decompensated heart failure: a U.S. center\u2019s experience","volume":"8","author":"Griffin","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib89","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/eurheartj\/ehv755","article-title":"Agents with vasodilator properties in acute heart failure","volume":"38","author":"Singh","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ejhf.889","article-title":"Systolic blood pressure reduction during the first 24 h in acute heart failure admission: friend or foe?","volume":"20","author":"Cotter","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib92","first-page":"1531","article-title":"Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF). Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib93","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1001\/jama.2019.18598","article-title":"Effect of a strategy of comprehensive vasodilation vs usual care on mortality and heart failure rehospitalization among patients with acute heart failure: the GALACTIC randomized clinical trial","volume":"322","author":"Kozhuharov","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib94","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1056\/NEJMoa1601895","article-title":"Effect of ularitide on cardiovascular mortality in acute heart failure","volume":"376","author":"Packer","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(12)61855-8","article-title":"Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial","volume":"381","author":"Teerlink","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2021.01.002_bib96","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.jacc.2012.07.011","article-title":"Hospital patterns of use of positive inotropic agents in patients with heart failure","volume":"60","author":"Partovian","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib97","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ejhf.991","article-title":"Long-term safety of intravenous cardiovascular agents in acute heart failure: results from the European Society of Cardiology Heart Failure Long-Term Registry","volume":"20","author":"Mebazaa","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib98","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1161\/CIRCHEARTFAILURE.113.000761","article-title":"American Heart Association\u2019s Get With The Guidelines Heart Failure Investigators. Hospital variation in intravenous inotrope use for patients hospitalized with heart failure: insights from Get With the Guidelines","volume":"7","author":"Allen","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib99","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejheart.2005.12.003","article-title":"Clinical trials update from the American Heart Association: REPAIR-AMI, ASTAMI, JELIS, MEGA, REVIVE-II, SURVIVE, and PROACTIVE","volume":"8","author":"Cleland","year":"2006","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib100","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib101","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0735-1097(02)02968-6","article-title":"Heart failure etiology and response tomilrinone in decompensated heart failure: results from the OPTIME-CHF study","volume":"41","author":"Felker","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib102","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jchf.2012.12.004","article-title":"Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure","volume":"1","author":"Packer","year":"2013","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib103","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib104","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.jacc.2019.02.051","article-title":"Cardiac calcitropes, myotropes, and mitotropes: JACC Review Topic of the Week","volume":"73","author":"Psotka","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib105","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","article-title":"Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE randomized trial","volume":"297","author":"Mebazaa","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.cjca.2021.01.002_bib106","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/ejhf.1743","article-title":"Treatment with 24 hour istaroxime infusion in patients hospitalised for acute heart failure: a randomised, placebo-controlled trial","volume":"22","author":"Carubelli","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib107","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jchf.2019.12.001","article-title":"Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: rationale and design of GALACTIC-HF","volume":"8","author":"Teerlink","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib108","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.jacc.2016.01.031","article-title":"Acute Treatment with Omecamtiv Mecarbil to Increase Contractility in Acute Heart Failure: the ATOMIC-AHF Study","volume":"67","author":"Teerlink","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2021.01.002_bib109","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cardfail.2006.10.012","article-title":"Fluid restriction in the management of decompensated heart failure: no impact on time to clinical stability","volume":"13","author":"Travers","year":"2007","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib110","article-title":"Current management of hyponatremia in acute heart failure: a report from the Hyponatremia Registry for patients with euvolemic and hypervolemic hyponatremia (HN Registry)","volume":"6","author":"Dunlap","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2021.01.002_bib111","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1001\/jamainternmed.2013.552","article-title":"Aggressive fluid and sodium restriction in acute decompensated heart failure: a randomized clinical trial","volume":"173","author":"Aliti","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib112","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/14017430802071200","article-title":"Liberal versus restricted fluid prescription in stabilised patients with chronic heart failure: result of a randomised cross-over study of the effects on health-related quality of life, physical capacity, thirst and morbidity","volume":"42","author":"Holst","year":"2008","journal-title":"Scand Cardiovasc J"},{"key":"10.1016\/j.cjca.2021.01.002_bib113","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cardfail.2010.11.008","article-title":"Three gram sodium intake is associated with longer event-free survival only in patients with advanced heart failure","volume":"17","author":"Lennie","year":"2011","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib114","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jchf.2019.04.023","article-title":"Exercise-based rehabilitation for heart failure: Cochrane systematic review, meta-analysis, and trial sequential analysis","volume":"7","author":"Taylor","year":"2019","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jchf.2016.12.019","article-title":"A\u00a0novel rehabilitation intervention for older patients with acute decompensated heart failure: the REHAB-HF pilot study","volume":"5","author":"Reeves","year":"2017","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib116","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4103\/1995-705X.95064","article-title":"Effects of combined early in-patient cardiac rehabilitation and structured home-based program on function among patients with congestive heart failure: a randomized controlled trial","volume":"12","author":"Babu","year":"2011","journal-title":"Heart Views"},{"key":"10.1016\/j.cjca.2021.01.002_bib117","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/HCR.0b013e31823be124","article-title":"Inpatient cardiac rehabilitation soon after hospitalization for acute decompensated heart failure: a propensity score study","volume":"32","author":"Scrutinio","year":"2012","journal-title":"J\u00a0Cardiopulm Rehabil Prev"},{"key":"10.1016\/j.cjca.2021.01.002_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.ahj.2006.10.008","article-title":"Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: an analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)","volume":"153","author":"Fonarow","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jchf.2015.03.008","article-title":"Effects of beta-blocker withdrawal in acute decompensated heart failure: a systematic review and meta-analysis","volume":"3","author":"Prins","year":"2015","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejheart.2008.01.014","article-title":"Acute heart failure in the emergency department: short and long-term outcomes of elderly patients with heart failure","volume":"10","author":"Ezekowitz","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib121","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1093\/eurheartj\/ehp323","article-title":"B-CONVINCED: Beta-blocker CONtinuation Vs. INterruption in patients with Congestive heart failure hospitalizED for a decompensation episode","volume":"30","author":"Jondeau","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2021.01.002_bib122","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2021.01.002_bib123","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cjca.2021.01.002_bib124","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ejhf.1670","article-title":"Initiation of sacubitril\/valsartan shortly after hospitalisation for acutely decompensated heart failure in patients with newly diagnosed (de novo) heart failure: a subgroup analysis of the TRANSITION study","volume":"22","author":"Senni","year":"2020","journal-title":"Eur J Heart Fail"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21000027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X21000027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:46:31Z","timestamp":1760107591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X21000027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":122,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0828282X21000027"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2021.01.002","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evidence-Based Management of Acute Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}